معرفی
Bing Xu is the Charles A. Breskin Chair in Organic Chemistry and Professor of Chemistry at Brandeis University. His research integrates organic chemistry, materials science, and nanotechnology to develop biofunctional materials for biomedical applications, such as cancer therapy, drug delivery, and molecular diagnostics. Xu’s work focuses on enzymatic noncovalent synthesis and supramolecular self-assembly to create materials that interact with biological systems at the cellular and molecular levels.
- Education: PhD from the University of Pennsylvania (1996), MS and BS from Nanjing University (1990, 1987).
- Awards: 2014 Highly-cited researcher (Thompson Reuters), Kenneth Rainin Innovator Award (2013), DuPont Young Investigator Award (2001).
Research emphasizes designing peptides and small molecules that self-assemble in response to enzymatic activity, enabling targeted drug delivery and organelle-specific therapies. Key areas include Golgi and mitochondrial targeting, anti-cancer nanomaterials, and enzyme-responsive hydrogels. Xu has published over 250 peer-reviewed articles, with an h-index of 78 (Google Scholar).
His lab develops multifunctional biomaterials for imaging and treating diseases, including cancer and infections. Collaborative projects involve materials engineering, cell biology, and clinical applications, supported by grants from NSF, NIH, and international foundations.
